Global Multivalent Vaccines Market Study 2015-2025, by Segment (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, … …), by Market (Pediatrics, Adults), by Company (GlaxoSmithKline, plc (U.K.), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), … …)

November 2018 | 72 pages | ID: GB19BF43B91EN
99Strategy

Abstracts

Snapshot

The global Multivalent Vaccines market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Pediatrics
• Adults

Company Coverage (Sales data, Main Products & Services etc.):

• GlaxoSmithKline, plc (U.K.)
• Pfizer, Inc. (U.S.)
• Merck & Co., Inc. (U.S.)
• Sanofi Pasteur SA (France)
• Astellas Pharma Inc. (Japan)
• CSL Limited (Australia)
• Emergent BioSolutions, Inc. (U.S.)
• Johnson & Johnson (U.S.)
• MedImmune, LLC (U.S.)
• Serum Institute of India Pvt. Ltd. (India)
• Bavarian Nordic (Denmark)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Daiichi Sankyo (Japan)
• Protein Sciences Corporation (U.S.)
• Panacea Biotec (India)

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Multivalent Vaccines Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 MULTIVALENT VACCINES MARKET BY TYPE

2.1 By Type
  2.1.1 Conjugate Vaccines
  2.1.2 Inactivated and Subunit Vaccines
  2.1.3 Live Attenuated Vaccines
  2.1.4 Toxoid Vaccines
  2.1.5 Recombinant Vaccines
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Pediatrics
  3.1.2 Adults
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 GlaxoSmithKline, plc (U.K.) (Company Profile, Sales Data etc.)
5.2 Pfizer, Inc. (U.S.) (Company Profile, Sales Data etc.)
5.3 Merck & Co., Inc. (U.S.) (Company Profile, Sales Data etc.)
5.4 Sanofi Pasteur SA (France) (Company Profile, Sales Data etc.)
5.5 Astellas Pharma Inc. (Japan) (Company Profile, Sales Data etc.)
5.6 CSL Limited (Australia) (Company Profile, Sales Data etc.)
5.7 Emergent BioSolutions, Inc. (U.S.) (Company Profile, Sales Data etc.)
5.8 Johnson & Johnson (U.S.) (Company Profile, Sales Data etc.)
5.9 MedImmune, LLC (U.S.) (Company Profile, Sales Data etc.)
5.10 Serum Institute of India Pvt. Ltd. (India) (Company Profile, Sales Data etc.)
5.11 Bavarian Nordic (Denmark) (Company Profile, Sales Data etc.)
5.12 Mitsubishi Tanabe Pharma Corporation (Japan) (Company Profile, Sales Data etc.)
5.13 Daiichi Sankyo (Japan) (Company Profile, Sales Data etc.)
5.14 Protein Sciences Corporation (U.S.) (Company Profile, Sales Data etc.)
5.15 Panacea Biotec (India) (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table GLOBAL MULTIVALENT VACCINES MARKET 2015-2018, BY TYPE, IN USD MILLION
Table Global Multivalent Vaccines Market 2015-2018, by Type, in Volume
Table Global Multivalent Vaccines Market Forecast 2019-2025, by Type, in USD Million
Table Global Multivalent Vaccines Market Forecast 2019-2025, by Type, in Volume
Table GlaxoSmithKline, plc (U.K.) Overview List
Table Multivalent Vaccines Business Operation of GlaxoSmithKline, plc (U.K.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. (U.S.) Overview List
Table Multivalent Vaccines Business Operation of Pfizer, Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co., Inc. (U.S.) Overview List
Table Multivalent Vaccines Business Operation of Merck & Co., Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Pasteur SA (France) Overview List
Table Multivalent Vaccines Business Operation of Sanofi Pasteur SA (France) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Pharma Inc. (Japan) Overview List
Table Multivalent Vaccines Business Operation of Astellas Pharma Inc. (Japan) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Limited (Australia) Overview List
Table Multivalent Vaccines Business Operation of CSL Limited (Australia) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Emergent BioSolutions, Inc. (U.S.) Overview List
Table Multivalent Vaccines Business Operation of Emergent BioSolutions, Inc. (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson (U.S.) Overview List
Table Multivalent Vaccines Business Operation of Johnson & Johnson (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedImmune, LLC (U.S.) Overview List
Table Multivalent Vaccines Business Operation of MedImmune, LLC (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Serum Institute of India Pvt. Ltd. (India) Overview List
Table Multivalent Vaccines Business Operation of Serum Institute of India Pvt. Ltd. (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bavarian Nordic (Denmark) Overview List
Table Multivalent Vaccines Business Operation of Bavarian Nordic (Denmark) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Overview List
Table Multivalent Vaccines Business Operation of Mitsubishi Tanabe Pharma Corporation (Japan) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo (Japan) Overview List
Table Multivalent Vaccines Business Operation of Daiichi Sankyo (Japan) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Protein Sciences Corporation (U.S.) Overview List
Table Multivalent Vaccines Business Operation of Protein Sciences Corporation (U.S.) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Panacea Biotec (India) Overview List
Table Multivalent Vaccines Business Operation of Panacea Biotec (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Multivalent Vaccines Market Growth 2015-2018, by Type, in USD Million
Figure Global Multivalent Vaccines Market Growth 2015-2018, by Type, in Volume